Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors

Journal of Drug Targeting

Volumn 16, Issue 5, 2008, Pages 424-435

  Senthilkumar, Murugesan ^a   Mishra, Pradeep ^a   Jain, Narendra Kumar ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Docetaxel; Nanoparticles; Pharmacokinetics; PLGA mPEG; Solid tumor

Indexed keywords

COPOLYMER; DOCETAXEL; NANOPARTICLE; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BIOCOMPATIBILITY; CANCER INHIBITION; CELL ASSAY; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; PRIORITY JOURNAL; SOLID TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; CELL LINE, TUMOR; CHROMATOGRAPHY, GEL; DRUG CARRIERS; FEMALE; HALF-LIFE; HUMANS; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED BALB C; NANOPARTICLES; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; POLYGLYCOLIC ACID; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TAXOIDS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 46649114006     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860802088598     Document Type: Article

References (31)

1. Alexis, F. (2005) Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Polym Int, 54, pp. 36-46.
2. Avgoustakis, K. (2004) Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: Preparation, properties and possible applications in drug delivery. Curr Drug Deliv, 1, pp. 321-333.
3. Bazile, D., Prudhomme, C., Bassoullet, MT, Marlard, M., Spenlenhauer, G. and Veillard, M. (1995) Stealth Me-PEG-PLA nanoparticles avoid uptake by the mononuclear phagocyte system. J Pharm Sci, 84, pp. 493-498.
4. Brigger, I., Dubernet, C. and Couvreur, P. (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev, 54, pp. 631-651.
5. Capri, G., Tarenzi, E., Fulfaro, F. and Gianni, L. (1996) The role of taxanes in the treatment of breast cancer. Semin Oncol, 23, pp. 68-75.
6. Dong, Y. and Feng, SS (2004) Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anti cancer drugs. Biomaterials, 25, pp. 2843-2849.
7. Garg, MB and Ackland, SB (2000) Simple and sensitive high-performance liquid chromatography method for the determination of Docetaxel in human plasma or urine. J Chromatogr B, 748, pp. 383-388.
8. Garrec, DL, Gori, S., Luo, L., Lessard, D., Smith, DC, Yessine, MA, Ranger, M. and Leroux, JC (2004) Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anti cancer drugs: In vitro and in vivo evaluation. J Control Release, 99, pp. 83-101.
9. Gref, R., Minamitake, Y., Perachia, MT, Trubetskoy, V., Torchilin, V. and Langer, R. (1994) Biodegradable long circulating polymeric nanospheres. Science, 263, pp. 1600-1603.
10. Gref, R., Domp, A., Quellec, P., Blunk, T., Muller, RH, Verbavatz, JM and Langer, R. (1995) The controlled intravenous delivery of drugs using PEG coated sterically stabilized nanospheres. Adv Drug Deliv Rev, 16, pp. 215-233.
11. Grosse, PY, Bressolle, F. and Pinguet, F. (1998) In vitro modulation of doxorubicin and Docetaxel antitumoral activity by methyl-β-cyclodextrin. Eur J Cancer, 34, pp. 168-174.
12. Hans, ML and Lowman, AM (2002) Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci, 6, pp. 319-327.
13. Immordino, ML, Brusa, P., Arpicco, S., Stella, B., Dosio, F. and Cattel, L. (2003) Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing Docetaxel. J Control Release, 91, pp. 417-429.
14. Jeong, JH, Lim, DW, Han, DK and Park, TG (2000) Synthesis, characterization and protein adsorption behaviors of PLGA/PEG di-block co-polymer blend films. Colloids Surf B Biointerfaces, 18, pp. 371-379.
15. Khalid, MN, Simard, P., Hoarau, D., Dragomir, A. and Leroux, JC (2006) Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver Docetaxel to solid tumors. Pharm Res, 23, pp. 752-758.
16. Na, K. and Bae, YH (2002) Self-assembled hydrogel nanoparticles responsive to tumor extracellular pH from pullulan derivative/ sulfonamide conjugate: Characterization, aggregation, and adiramycin release in vitro. Pharm Res, 19, pp. 681-688.
17. Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T. and Maeda, H. (1998) Early phase tumor accumulation of macromolecules: A great differences in clearance rate between tumor and normal tissues. Jpn J Cancer Res, 89, pp. 307-314.
18. Ojima, I., Slater, JC, Michaud, E., Kuduk, SD, Bounaud, PY, Vrignaud, P., Bissery, MC, Veith, JM, Pera, P. and Bernacki, RJ (1996) Syntheses and structure-activity relationships of the second generation antitumor taxoids: Exceptional activity against drug-drug resistant cancer cells. J Med Chem, 39, pp. 3889-3896.
19. Panyam, J. and Labhasetwar, V. (2003) Dynamics of endocytosis and exocytosis of poly D,L-lactide-co-glycolide nanoparticles in vascular smooth muscle cells. Pharm Res, 20, pp. 212-220.
20. Peracchia, MT, Gref, R., Minamitake, Y., Domb, A., Lotan, N. and Langer, R. (1997) PEG coated nanospheres from amphilic diblock and multiblock copolymer; investigation of their drug encapsulation and release characteristics. J Control Release, 46, pp. 223-231.
21. Qin, LY and Bae, YH (2006) Polymer architecture and drug delivery. Pharm Res, 23, pp. 1-30.
22. Rowinsky, EK (1997) The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med, 48, pp. 353-374.
23. Sahoo, SK, Panyam, J., Prabha, S. and Labhasetwar, V. (2002) Residual polyvinyl alcohol associated with poly(lactic-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release, 82, pp. 105-114.
24. Senthilkumar, M., Subramanian, G., Ranjit kumar, A, Nahar, M., Mishra, P. and Jain, NK (2007) PEGylated poly(lactide-co-glycolide) (PLGA) nanoparticulate delivery of Docetaxel: Synthesis of diblock copolymers, optimization of preparation variables on formulation characteristics and in vitro release studies. J Biomed Nanotech, 3, pp. 52-60.
25. Shenoy, D., Little, S., Langer, R. and Amiji, M. (2005) Ploy(ethylene oxide) modified poly(β-amino ester) nanoparticles as a pH sensitive system for tumor-targeted delivery of hydrophobic drugs; part 2 in vivo distribution and tumor localization studies. Pharm Res, 22, pp. 2107-2114.
26. Shi, B., Fang, C. and Pei, Y. (2006) Stealth PEG-PHDCA niosomes: Effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. J Pharm Sci, 95, pp. 1873-1887.
27. Stolink, S., Illum, L. and Davis, SS (1995) Long circulating micro particulate drug carriers. Adv Drug Deliv Rev, 16, pp. 195-214.
28. Strom, G., Beliot, SO, Daemen, T. and Lasic, DD (1995) Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev, 17, pp. 191-199.
29. Vijayan, P., Vijayaraj, P., Setty, PHC, Hariharapura, RC, Godavarthi, A., Badami, S., Arumugam, DS and Bhojraj, S. (2004) The cytotoxicity activity of the total alkaloids isolated from different parts of solanum pseudocapsicum. Biol Pharm Bull, 27, pp. 528-530.
30. Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K. and Kataoka, K. (1999) Selective delivery of adiramycin to a solid tumor using a polymeric micelle carrier system. J Drug Target, 7, pp. 171-186.
31. Yoo, HS and Park, TG (2001) Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J Control Release, 70, pp. 63-70.